[Research Articles] Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia

This study thus identifies a pathogenic contributor to autoimmune diseases that can be targeted by available therapeutic agents.

Source: Science Translational Medicine - April 14, 2021 Category: Biomedical Science Authors: Crickx, E., Chappert, P., Sokal, A., Weller, S., Azzaoui, I., Vandenberghe, A., Bonnard, G., Rossi, G., Fadeev, T., Storck, S., Fadlallah, J., Meignin, V., Riviere, E., Audia, S., Godeau, B., Michel, M., Weill, J.-C., Reynaud, C.-A., Mahevas, M. Tags: Research Articles Source Type: research